M. Shindo et al.
Phytochemistry 179 (2020) 112508
Fig. 10. Inhibitory activity tests of gravitropic bending and elongation for benzocarbocyclic analogues 2 (50
μ
M, unless otherwise noted). Data for gravitropic
bending (left) and elongation (right) represent mean ± SD. Asterisk indicates statistically significant differences between treatments and controls at p < 0.05
(Dunnett’s test, n = 7).
bending.
12.2 Hz, 1H), 6.71 (d, J = 12.2 Hz, 1H), 6.75 (s, 1H), 7.14–7.21 (m, 4H);
13C-NMR (150 MHz, CDCl3) δ: 29.9 (t), 31.6 (t), 34.7 (t), 116.8 (d),
125.9 (d), 127.6 (d), 129.2 (d), 131.1 (d), 136.2 (s), 137.1 (d), 139.1 (s),
142.1 (s), 148.9 (d), 171.6 (s); IR (KBr) 1686 cmꢀ 1; EIMS m/z 214 (M+,
100%); Elem. Anal. calcd for C14H14O2: C, 78.48; H, 6.59. found: C,
78.28; H, 6.71.
2a: colorless prism (219.0 mg, 70%, Z:E = >99:1), mp. 104–105 ◦C
(hexane/EtOAc); 1H-NMR (270 MHz, CDCl3) δ: 2.65 (t, J = 7.8 Hz, 2H),
2.84 (t, J = 7.8 Hz, 2H), 5.78 (d, J = 12.5 Hz, 1H), 6.69 (d, J = 12.5 Hz,
1H), 6.76 (s, 1H), 7.08–7.19 (m, 4H); 13C-NMR (100 MHz, CDCl3) δ:
26.0 (t), 28.1 (t), 116.6 (d), 126.6 (d), 127.24 (d), 127.26 (d), 128.3 (d),
133.6 (s), 135.1 (d), 136.26 (s), 136.28 (s), 146.2 (d), 171.8 (s); IR (KBr)
1690 cmꢀ 1; EIMS m/z 200 (M+, 100%); Elem. Anal. calcd for C13H12O2:
C, 77.98; H, 6.04, found: C, 77.86; H, 6.00.
3.2.4. Synthesis of (Z)-3-(benzo[b]thiophen-2-yl)acrylic acid (3a)
The title compound was synthesized according to the procedure of
4.2.1. from benzo[b]thiophene-2-carboxaldehyde.
3.2.2. Synthesis of (Z)-3-(1H-inden-2-yl)acrylic acid (2b)
3a: starting from 877 mg of the aldehyde; colorless needles (87% for
1
◦
The title compound was synthesized according to the procedure of
4.2.1. from 1H-indene-2-carbaldehyde.
2 steps, Z:E = >99:1), mp. 154–156 C (CH3CN); H-NMR (400 MHz,
CDCl3) δ: 5.92 (d, J = 12.6 Hz, 1H), 7.17 (d, J = 12.6 Hz, 1H), 7.33–7.40
(m, 2H), 7.67 (s, 1H), 7.78–7.83 (m, 2H); 13C-NMR (150 MHz, Acetone-
d6) δ: 117.5 (d), 122.9 (d), 125.1 (d), 125.3 (d), 126.8 (d), 133.3 (d),
Ethyl ester of 2b: starting from 22 mg of the aldehyde: yellow oil
(22%, Z:E = >99:1); 1H-NMR (600 MHz, CDCl3) δ: 1.34 (t, J = 7.0 Hz,
3H), 3.94 (s, 2H), 4.24 (q, J = 7.0 Hz, 2H), 5.75 (d, J = 12.4 Hz, 1H),
6.86 (d, J = 12.4 Hz, 1H), 7.22 (s, 1H), 7.42 (d, J = 6.9 Hz, 1H), 7.47 (d,
J = 6.9 Hz, 1H); 13C-NMR (150 MHz, CDCl3) δ: 14.3 (q), 40.9 (t), 60.1
(t), 116.7 (d), 122.0 (d), 123.9 (d), 126.5 (2C, d), 138.0 (d), 140.7 (d),
143.2 (s), 143.5 (s), 145.4 (s), 166.3 (s); IR (NaCl) 1721 cmꢀ 1; EIMS m/z
214 (M+), 168 (100%); HRMS (FAB) Calcd for C14H14O2 (M+):
214.0994, found: 214.0993.
137.6 (d), 138.8 (s), 139.2 (s), 143.9 (s), 167.2 (s); IR (KBr) 1680 cmꢀ 1
;
EIMS m/z 204 (M+, 100%); Elem. Anal. calcd for C11H8O2S: C, 64.69; H,
3.95, found: C, 64.58; H, 3.87.
3.2.5. Synthesis of (Z)-3-(benzofuran-2-yl)acrylic acid (3b)
The title compound was synthesized according to the procedure of
4.2.1. from 2-benzofurancarboxaldehyde.
2b: starting from 399 mg of the ester; pale yellow prism (50%, Z:E =
Ethyl ester of 3b: starting from 438 mg of the aldehyde; colorless oil
(97%, Z:E = >99:1); 1H-NMR (400 MHz, CDCl3) δ: 1.35 (t, J = 7.1 Hz,
3H), 4.28 (q, J = 7.1 Hz, 2H), 5.96 (d, J = 13.0 Hz, 1H), 6.88 (d, J = 13.0
Hz, 1H), 7.21–7.25 (m, 1H), 7.31–7.35 (m, 1H), 7.44 (d, J = 8.2 Hz, 1H),
7.62 (d, J = 7.7 Hz, 1H), 7.95 (s, 1H); 13C-NMR (100 MHz, CDCl3) δ:
14.3 (q), 60.5 (t), 111.2 (d), 112.5 (d), 118.6 (d), 122.2 (d), 123.1 (d),
126.1 (d), 128.8 (s), 130.2 (d), 151.6 (s), 154.8 (s), 165.8 (s); IR (NaCl)
1718 cmꢀ 1; EIMS m/z 216 (M+, 100%); Elem. Anal. calcd for C13H12O3:
C, 72.21; H, 5.59, found: C, 72.30; H, 5.51.
1
◦
>99:1); mp. 121–123 C (hexane: AcOEt = 9:1); H-NMR (400 MHz,
CDCl3) δ: 3.97 (s, 2H), 5.80 (d, J = 12.6 Hz, 1H), 6.99 (d, J = 12.6 Hz,
1H), 7.26–7.32 (m, 3H), 7.44–7.51 (m, 2H); 13C-NMR (150 MHz, CDCl3)
δ: 40.9 (t), 115.2 (d), 122.2 (d), 124.0 (d), 126.6 (d), 126.9 (d), 140.5
(d), 142.3 (d), 143.0 (s), 143.3 (s), 145.7 (s), 171.0 (s); IR (KBr) 1686
cmꢀ 1; EIMS m/z 186 (M+), 168 (100%); HRMS (FAB) Calcd for
C
12H10O2 (M+): 186.0681, found: 168.0685.
3.2.3. Synthesis of (Z)-3-(6,7-dihydro-5H-benzo[7]annulen-8-yl)acrylic
acid (2c)
3b: starting from 500 mg of the ester; colorless prism (93%, Z:E =
>99:1), mp. 147–149 ◦C (CH3CN); 1H-NMR (400 MHz, CDCl3) δ: 5.99
(d, J = 13.0 Hz, 1H), 6.91 (d, J = 13.2 Hz, 1H), 7.24 (t, J = 7.6, 7.6 Hz,
1H), 7.34 (dd, J = 7.6, 7.6 Hz, 1H), 7.46 (d, J = 7.6 Hz, 1H), 7.62 (d, J =
7.6 Hz, 1H), 7.89 (s, 1H); 13C-NMR (100 MHz, acetone-d6) δ: 111.9 (d),
112.9 (d), 120.2 (d), 123.1 (d), 124.1 (d), 127.1 (d), 129.7 (s), 130.7 (d),
152.8 (s), 155.5 (s), 167.0 (s); IR (KBr) 1701 cmꢀ 1; EIMS m/z 188 (M+,
100%); Elem. Anal. calcd for C11H8O3: C, 70.21; H, 4.29, found: C,
69.91; H, 4.24.
The title compound was synthesized according to the procedure of
4.2.1. from 6,7-dihydro-5H-benzo[7]annulene-8-carbaldehyde.
Ethyl ester of 2c: starting from 399 mg of the aldehyde; pale yellow
oil (29%, Z:E = >99:1); 1H-NMR (270 MHz, CDCl3) δ: 1.27 (t, J = 7.2 Hz,
4H), 2.11–2.16 (m, 2H), 2.47 (t, J = 6.6 Hz, 2H), 2.79–2.83 (m, 2H),
4.18 (q, J = 7.2 Hz, 2H), 5.73 (d, J = 12.6 Hz, 1H), 6.56 (d, J = 12.6 Hz,
1H), 6.70 (s, 1H), 7.09–7.19 (m, 4H).
2c: starting from 159 mg of the ester; colorless needles (94%, Z:E =
>99:1); mp. 58–59 ◦C (hexane); 1H-NMR (400 MHz, CDCl3) δ: 2.11–2.18
(m, 2H), 2.49 (t, J = 6.5 Hz, 2H), 2.80 (t, J = 6.0 Hz, 2H), 5.76 (d, J =
3.2.6. Synthesis of (Z)-3-(1H-indol-2-yl) acrylic acid (3c)
The title compound was synthesized according to the procedure of
6